APA (7th ed.) Citation

Doll, J. A., Neely, M. L., Roe, M. T., Armstrong, P. W., White, H. D., Prabhakaran, D., . . . Fox, K. A. (2016). Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel. Journal of the American College of Cardiology, 67(8), 936-947. https://doi.org/10.1016/j.jacc.2015.12.036

Chicago Style (17th ed.) Citation

Doll, Jacob A., et al. "Impact of CYP2C19 Metabolizer Status On Patients With ACS Treated With Prasugrel Versus Clopidogrel." Journal of the American College of Cardiology 67, no. 8 (2016): 936-947. https://doi.org/10.1016/j.jacc.2015.12.036.

MLA (9th ed.) Citation

Doll, Jacob A., et al. "Impact of CYP2C19 Metabolizer Status On Patients With ACS Treated With Prasugrel Versus Clopidogrel." Journal of the American College of Cardiology, vol. 67, no. 8, 2016, pp. 936-947, https://doi.org/10.1016/j.jacc.2015.12.036.